Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cal Gary who wrote (7731)	9/25/2001 11:52:18 AM
From: David Graham	Read Replies (1) of 14101

FDA: Merck Misleads on Vioxx Safety Tuesday September 25 11:27 AM ET WASHINGTON (AP) - The government has ordered Merck & Co. to cease promotions aimed to get doctors to prescribe its blockbuster arthritis painkiller Vioxx, saying they minimize potential safety risks. The Food and Drug Administration (news - web sites) told Merck to set the record straight by sending a ``Dear Doctor'' letter to all health workers who may have been exposed to the misleading campaign. Merck has until Oct. 1 to respond. The main issue: Whether Vioxx users face an increased risk of heart attacks and strokes. A recent study comparing Vioxx to another painkiller, naproxen, suggested they do. Many heart experts are divided about the risk and want more research. But an FDA advisory panel has said Vioxx should carry a warning label about the potential risk. Merck has argued that Vioxx falsely looked risky because naproxen thins the blood much like aspirin does and thus protected against heart attacks. It aired that view in the recent promotions that state, ``Vioxx is a wonderful, effective'' painkiller but not one that has a blood-thinning side benefit. ``In fact, the situation is not at all clear,'' the FDA responded, saying no studies prove naproxen thins blood enough to explain the discrepancy. ``The company continues to stand behind the overall safety and cardiovascular safety of Vioxx,'' said Merck spokeswoman Jan Weiner. DMX should post this stuff on their site.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next